Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

KeraVision corneal ring myopia study finds vision of at least 20/40 in 85% of patients -- IPO.

This article was originally published in The Gray Sheet

Executive Summary

KERAVISION ICR INTRASTROMAL CORNEAL RING PHASE II MYOPIA STUDY has found vision improvement to 20/40 or better among 85% of patients with six-month or longer follow-up, the firm reports in a June 5 registration statement with the Securities and Exchange Commission for an initial public offering. "As of their most recent examinations," the filing states, "85% of the 82 patients with the corneal ring had uncorrected visual acuity of 20/40 or better, the legal requirement in most states to obtain a driver's license without corrective lenses." With the addition of corrective lenses, one patient had vision of 20/25 and the remainder had 20/20 or better.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004228

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel